Day 1 of 2: FDA Pharmacy Compounding Advisory Committee, which includes physicians who promote unproven peptides, votes 8 - 6 - 1 to place the free base and acetate forms of unproven peptides on the Agency's 503A bulk drugs compounding list

Day 1 of 2: FDA Pharmacy Compounding Advisory Committee, which includes physicians who promote unproven peptides, votes 8 - 6 - 1 to place the free base and acetate forms of unproven peptides on the Agency's 503A bulk drugs compounding list